Tag: Sickle Cell Disease
-

Vertex to Present at UBS Global Healthcare Conference 2025
Vertex Announces Participation in UBS Global Healthcare Conference Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced today that its leadership will participate in the UBS Global Healthcare Conference. Reshma Kewalramani, President and Chief Executive Officer of Vertex, is scheduled to take part in a fireside chat on Tuesday, November 11, 2025, at 10:15 a.m. Eastern Time. The…
